A sustainability officer at a regional health authority is drafting an RFP for compostable waste bags and patient underpads. Three suppliers respond within a week: one quoting Polyhydroxyalkanoates (PHA), another quoting polylactic acid (PLA), and a third offering both. Which polymer family should the contract favor, and who actually makes the resin inside those products? The answers shape price, certification, and supply security for the life of the agreement.
NatureWorks: the established producer behind Ingeo PLA
NatureWorks, a wholly owned subsidiary of Thailand's GC International Corporation, runs the world's largest PLA production site in Blair, Nebraska. Its Ingeo brand has anchored the polylactic acid market since the early 2000s, and annual capacity of roughly 150,000 tonnes still dwarfs most competitors. For converters, that scale means consistent quality, dependable logistics, and a supply chain that food-service and hygiene brands already rely on.
The limitations are material-based rather than commercial. Ingeo PLA delivers good clarity and stiffness, but heat resistance is modest and the polymer can be brittle in thin films. It composts dependably in industrial facilities under controlled temperature and humidity, yet breaks down slowly in marine and home-compost environments. Facilities that need those end-of-life profiles should look closely at the PHA side of the market.

The PHA producers: Danimer, Kaneka, CJ, and Newlight
For buyers comparing bioplastic producers, four names recur on the PHA side of the market. Each brings real strengths, and each has limitations worth knowing before you commit to a specification.
- Danimer Scientific — its Nodax resin targets straws, packaging, and coatings, backed by a broad PHA patent portfolio. Strengths: certified marine biodegradability and long-standing brand partnerships. Limitations: production capacity has ramped slowly and the company's finances have been volatile.
- Kaneka — the Japanese chemical firm makes Green Planet PHBH at a dedicated plant in Takasago. Strengths: food-contact approvals and a reputation for batch-to-batch consistency. Limitations: output is modest next to PLA volumes, which keeps PHA pricing firm.
- CJ CheilJedang — the South Korean food and biotech group sells PHA under the PHACT brand, drawing on fermentation capacity few resin makers can match. Strengths: scale-up know-how and cost-down discipline. Limitations: a newer name in polymer distribution.
- Newlight — its AirCarbon material is produced from methane and carbon dioxide captured from greenhouse gas streams. Strengths: a distinctive carbon-negative story that resonates with climate-conscious buyers. Limitations: output remains limited and most volume goes to specialty applications.
NatureWorks vs PHA: market dynamics and what the data shows
Market data explains why procurement teams now treat both families as strategic. Grand View Research values the global PLA market at more than USD 1.5 billion in 2024 and projects double-digit annual growth through 2030 on the back of single-use substitution. European Bioplastics, meanwhile, puts total bioplastics production capacity near 2.5 million tonnes a year, with PLA the largest rigid segment and the polyhydroxyalkanoates market the fastest-growing family in percentage terms as new plants come online in Asia, Europe, and North America.
The price gap is narrowing as well. PLA benefits from mature scale, while PHA producers keep pushing fermentation costs down as capacity expands. For buyers, the practical difference now comes down to end-of-life requirements: industrial compostability, home compostability, marine biodegradability, and recyclability all map differently onto PLA versus PHA.
What this means for medical supply buyers
For hospitals, long-term care homes, and distributors, the producer landscape matters as much as the polymer chemistry. A resin made at a single site creates concentration risk; a family with several qualified suppliers gives procurement room to negotiate. Certification also differs: industrial compostability claims are usually verified against ASTM D6400 or EN 13432, while PHA's marine biodegradability claims carry their own test methods. Our side-by-side look at PLA versus PHA covers the property differences in detail, and the PHA guide for medical supplies explains how the family behaves in clinical settings.

Where CliniEco fits
CliniEco sits downstream of these producers. We buy resin and finished goods from multiple qualified converters and carry both PLA and PHA product lines, so procurement teams can match the polymer to the application rather than the other way around. Our 30-gallon PLA biodegradable waste bags, for instance, suit facilities that compost organics, while PHA-based underpads serve settings where end-of-life flexibility matters more. Neither family is a universal answer; that is why we offer both and why we stay transparent about what each can and cannot do. If you are evaluating compostable disposables, browse the CliniEco medical supply catalog or contact us and we will help you map requirements to the right resin.
Related Products
Related Reading
Explore more guides in this category:
- Quat vs Bleach vs Alcohol Wipes: Disinfectant Chemistry Explained
- Wound Dressing Basics: Gauze, ABD Pads & Bandages Explained
- ISO 11140-1 Explained: Chemical Indicator Classes for Sterilization
Related reading: explore our eco-friendly and sustainable product guides.
0 comments